According to a new report from Intel Market Research, the Asia-Pacific Anemia Drugs Market was valued at USD 2,450 million in 2024 and is projected to grow from USD 2,580 million in 2025 to USD 3,830 million by 2032, exhibiting a robust CAGR of approximately 5.8% during the forecast period. Market growth is driven by the region's high disease burden with an estimated 244 million women and 83...